Latest AusBiotech News | Page 9

AusBiotech connects sector to celebrate 2022
Telix acquires US radiochemistry business Optimal Tracers
Commercialisation key priority in future MRFF decisions
Brandon Capital Invests in neuroscience company NRG Therapeutics
BiomeBank announces world first regulatory approval for donor derived microbiome drug
QIMR and WEHI take home prizes for best early-stage project
Alterity Therapeutics updates on Multiple System Atrophy study
Telix announces positive topline results of late-stage imaging study
New AusBiotech Board fit for era
Federal Budget mostly ‘vanilla’, with bit of sting
Life sciences industry’s highest achievers celebrated at prestigious Awards ceremony
$5 million global challenge to boost health outcomes in Pilbara
Australia’s biggest week in biotech kicks off in Perth
World-class, locally developed: Australia’s largest annual biotech week kicks off
FDA submission triggers milestone payment for Neuren Pharmaceuticals
AusBiotech’s virtual 2022 AGM open to members
ANDHealth CEO recognised with ‘Telstra Brilliant Women in Digital Health Award’
Health Canada approves Telix’s Illuccix for prostate cancer imaging
Ag-Biotech Summit to feature sustainable food
Botanix announces positive BTX 1702 clinical study outcome
Illumina and AstraZenca team up on AI-based research project
Accelerating investment in Queensland’s early-stage companies
BioNTech chooses Melbourne for its Asia-Pacific mRNA R&D centre
IDT Australia announces new appointments to board of directors
International consultation on medicines and biologicals
Illumina unveils NovaSeq X series to accelerate genomic discoveries
Second fast-track designation for Australian immunotherapy company
Industry responds to proposed regulatory changes for clinical trials of medical devices
NATURE publishes data on DUNP19 receptors role in cancer growth
Move to expand Intellectual Property waiver presents concern
Australian biotechnology incubator Proto Axiom completes initial fundraising
Agilex Biolabs expands capacity with commissioning of new Brisbane facilty
CSL announces seven recipients of ‘Global Research Acceleration Initiative’ awards
New investor guide profiles biotech companies to watch
Botanix Pharmaceuticals submits new drug application to FDA
Alterity Therapeutics announces poster presentation from major study
Noxopharm founder to depart board as part of ‘natural evolution’
Medibio appoints experienced medical executive as new CEO
Noxopharm reports promising results from pancreatic cancer study
EpiAxis Therapeutics announces collaboration with Canadian research hospital
Linking biotech and investors: Stellar AusBioInvest 2022 programme launched
Asia Pacific takes lead in cell and gene clinical trials
Antisense Therapeutics announces revised clinical development plan for ATL1102
Imugene doses first patient in nextHERIZON Phase 2 clinical trial
Leading global health MD joins AusBiotech 2022 line-up
QIMR Berghofer grants and license agreement for potential vaccine
Recce Pharmaceuticals announces appointment of executive chairman
Framework released to facilitate university-industry partnerships